Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076296 · ClinicalTrials.gov registry record
A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System
A clinical trial of Pulmonary Hypertension and Heart Valve Diseases, sponsored by GE Healthcare.
- Completed
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT01076296 is a study of Pulmonary Hypertension and Heart Valve Diseases that has completed, run by GE Healthcare. The registered enrollment target is 1,000 participants, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01076296, a study of Pulmonary Hypertension and Heart Valve Diseases, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to collect data and learn more about the Vscan Ultrasound Imaging System. It is an "observational" study with no additional procedures or intervention prescribed other than using the Vscan along with a routine medical physical exam.
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01076296
The ClinicalTrials.gov registry entry for NCT01076296 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher). The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT01076296 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT01076296 about?
NCT01076296 is a clinical study titled "A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System". This study is to collect data and learn more about the Vscan Ultrasound Imaging System. It is an "observational" study with no additional procedures or intervention prescribed other than using the Vscan along with a routine medical physical exam.
What is the current status of trial NCT01076296?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2010-02. Estimated completion is 2012-07.
What conditions does trial NCT01076296 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Heart Valve Diseases, Left Ventricular Dysfunction, Right Ventricular Dysfunction.
Who is sponsoring clinical trial NCT01076296?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01076296 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.